En Es
Categories

DIAGNOSTICA STAGO

Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routine analysis
Products NewsSummary
Close

News of DIAGNOSTICA STAGO

Diagnostica Stago Introduces New MyOptiLab Workflow Analysis Service

30 Jun 2021
Diagnostica Stago Introduces New MyOptiLab Workflow Analysis Service
Diagnostica Stago (Asnières-sur-Seine, France) has introduced its new MyOptiLab workflow analysis service as part of a broader strategy aimed at working more closely with laboratories. It is an elaborate process designed to optimize organizational excellence.
Read More

Stago Connect.One Network Allows Remote Monitoring of Analyzers

09 Aug 2018
Stago Connect.One Network Allows Remote Monitoring of Analyzers
Diagnostica Stago, an in-vitro diagnostics company focusing on thrombosis and hemostasis, has launched the secure Connect.One network architecture, which allows laboratories to benefit from remote monitoring of their automated analyzers.
Read More

Stago Group Acquires HemoSonics

30 May 2017
Stago Group Acquires HemoSonics
The Stago Group, which develops and markets automated systems for blood analysis in coagulation, has completed the acquisition of HemoSonics LLC, a developer of point-of-care (POC) testing solutions.
Read More
Close

About DIAGNOSTICA STAGO

Number of Employees: 1000+
Year of Establishment: 1945
Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routine analysis
FaceBook Twitter Google+ Linked in
D-Dimer Immuno-Turbidimetric Assay

D-Dimer Immuno-Turbidimetric Assay

Model: STA-Liatest D-Di Plus
Request Information

Description:

STA-Liatest D-Di Plus was developed as an evolution of the STA-Liatest D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous Thrombo Embolism (VTE). In STA-Liatest D-Di Plus, the addition of a blocking agent improves the analytical and diagnostic performances of the assay by minimizing interferences to heterophilic antibodies, including rheumatoid factors (RF) and Human Anti-Mouse Antibodies (HAMA).
Read More

Full Description

Description

STA-Liatest D-Di Plus was developed as an evolution of the STA-Liatest D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous Thrombo Embolism (VTE). In STA-Liatest D-Di Plus, the addition of a blocking agent improves the analytical and diagnostic performances of the assay by minimizing interferences to heterophilic antibodies, including rheumatoid factors (RF) and Human Anti-Mouse Antibodies (HAMA). By minimizing the interferences from heterophilic antibodies, STA-Liatest D-Di Plus has been designed to show improved specificity for even more efficacy. Request Information

Send A Message To This Supplier

* Required Information
* Email
To
DIAGNOSTICA STAGO (D-Dimer Immuno-Turbidimetric Assay)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions